...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

Vetter To Expand its Secondary Packaging Service Capacity to Meet Rising Demands

| Print |
Thursday, 19 October 2017 16:00 (UTC + 2)

Vetter logo

Investment will contribute to a one-stop solution approach for customers  

  • Vetter is an expert in complex packaging for autoinjector and pen systems
  • Approximately 32,000 square feet expansion of the Vetter Secondary Packaging (VSP) will include new state-of-the art packaging lines and assembly equipment 
  • Expansion will satisfy growing customer and market demands for efficiency and novel packaging solutions

 
Ravensburg, Germany, October 19, 2017 / B3C newswire / --
Vetter, a global leader in prefilled drug-delivery systems and an expert in complex packaging projects, today announced a major expansion of its secondary packaging capacities as a response to rising customer needs and market demands for complex packaging solutions. The need for expansion is also a result of Vetter’s continuous growth in new filling lines and new lyophilizers, which is driving the need for increased downstream secondary packaging capacity. The project, already underway, is occurring within the second floor of Vetter’s existing Secondary Packaging (VSP) facility and will result in an increase of approximately 32,000 square feet of new packaging capacity.

The planned undertaking, which is expected to be completed over the next several years, will include new fully-automated packaging lines, space for manual and semi-automated packaging processes and assembly equipment for a wide variety of formats. The Vetter serialization and aggregation service, which fulfills current requirements and is prepared for future requirements of regulatory authorities, will also be expanded. A highly flexible, state-of-the-art syringe blister line will include safety device assembly and equipment for packaging Japan quality. The addition of new state-of-the-art assembly machines for pens and autoinjectors will allow Vetter to meet a majority of the growing market need for these systems. Because Vetter suppliers for the platform technologies are market leaders with a strong reputation in the market, a large selection of diverse pen and autoinjector types are offered.

“Often we hear from customers that a high level of expertise in the assembly and packaging of pens, autoinjectors and safety devices is critical for their success,” said Bernd Stauss, Senior Vice President Production/Engineering for Vetter. “Vetter has this experience and can offer a one-stop solution, from development to filling to secondary packaging including serialization of products; a service that is greatly appreciated by our customers.” The demand for integrated solutions is steadily growing. In the future, the pharmaceutical service provider will continue to expand its offering for one-stop-shop solutions - especially in complex areas such as the secondary packaging of end-user friendly devices which support patient safety, convenience and compliance. As a result, Vetter has an eye on the entire product life cycle of its customers with the usual high quality standards.

 Pic1

Caption:  The Vetter VSP facility in Ravensburg is being expanded to include state-of-the-art packaging and assembly equipment to meet the growing need for complex secondary packaging services
For high resolution please click the image.

Find the Vetter press kit, additional press releases, high-resolution pictures and more background information in our Download Center.


About Vetter
Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. The company has long-term experience offering services ranging from early development support including clinical manufacturing, to commercial supply and various packaging solutions for vials, syringes and cartridges. Vetter’s customers range from small and midsize to the world’s top 20 pharmaceutical and biotech companies. As a leading solution provider, the CDMO recognizes its responsibility in supporting the needs of its customers in developing devices that contribute to increased patient safety, convenience, and enhanced compliance.

 

Contact

Vetter Pharma International GmbH
Markus Kirchner
Corporate Spokesperson / Specialist External Communications
Eywiesenstrasse 5
88212 Ravensburg
Germany
+49 (0)751-3700-3729
This e-mail address is being protected from spambots. You need JavaScript enabled to view it